HIV-1 conserved mosaics delivered by regimens with integration-deficient, DC-targeting lentiviral vector induce robust T cells
To be effective against HIV-1, vaccine-induced T cells must selectively target epitopes, which are functionally conserved (present in the majority of currently circulating and reactivated HIV-1 strains) and, at the same time, beneficial (responses to which are associated with better clini...
Main Authors: | Hanke, T, Wee, E, Ondondo, B, Berglund, P, Archer, J, McMichael, A, Baltimore, D, ter Meulen, J |
---|---|
Format: | Journal article |
Published: |
Elsevier
2016
|
Similar Items
-
Lentiviral Vectors Delivered with Biomaterials as Therapeutics for Spinal Cord Injury
by: Ciara Shortiss, et al.
Published: (2021-08-01) -
The 2nd generation of a T-cell vaccine against HIV based on conserved region mosaics
by: Ondondo, B, et al.
Published: (2014) -
Integrase Defective Lentiviral Vector as a Vaccine Platform for Delivering Influenza Antigens
by: Alessandra Gallinaro, et al.
Published: (2018-02-01) -
LV305, a dendritic cell-targeting integration-deficient ZVexTM-based lentiviral vector encoding NY-ESO-1, induces potent anti-tumor immune response
by: Tina Chang Albershardt, et al.
Published: (2016-01-01) -
Lentiviral Vector Bioprocessing
by: Christopher Perry, et al.
Published: (2021-02-01)